K05.3
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Completion of active treatment for moderate to advanced chronic periodontitis, 2) absence of active periodontal therapy 3 months prior to enrollment, 3) presence of =2 teeth with a minimum of one BoP-positive site with a PPD of =4mm.
Exclusion criteria
Exclusion criteria: 1) any antibiotic therapy within 6 month prior to the study, 2) any indication for an endocarditis prophylaxis, 3) any diagnosis such as chronic bronchitis, asthma or a compromised immune system, and 4) any known hypersensitivity to sugar alcohol (polyol).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of test sites which do bleed after probing with a periodontal probe at baseline and six month after treatment with test or control treatment. | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduction of probing pocket depth and of the clinical attachment level measured six month after initial treatment with test or control treatment. Microbiological differences measured at baseline and six month after treatment by analysis of a microbiological sample taken from study sites. Time to treat at baseline to treat study sites by test or control therapy. | — |
Countries
Switzerland
Contacts
Klinik für Parodontologie, Zahnmedizinische Kliniken der Universität Bern